...
首页> 外文期刊>Molecular pharmacology. >The nucleotide-binding domains of sulfonylurea receptor 2A and 2B play different functional roles in nicorandil-induced activation of ATP-sensitive K+ channels.
【24h】

The nucleotide-binding domains of sulfonylurea receptor 2A and 2B play different functional roles in nicorandil-induced activation of ATP-sensitive K+ channels.

机译:磺酰脲受体2A和2B的核苷酸结合结构域在尼可地尔诱导的ATP敏感性K +通道激活中起不同的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Nicorandil activates ATP-sensitive K(+) channels composed of Kir6.2 and either sulfonylurea receptor (SUR) 2A or 2B. Although SUR2A and SUR2B differ only in their C-terminal 42 amino acids (C42) and possess identical drug receptors and nucleotide-binding domains (NBDs), nicorandil more potently activates SUR2B/Kir6.2 than SUR2A/Kir6.2 channels. Here, we analyzed the roles of NBDs in these channels' response to nicorandil with the inside-out configuration of the patch-clamp method. Binding and hydrolysis of nucleotides by NBDs were impaired by mutations in the Walker A motif of NBD1 (K708A) and NBD2 (K1349A) and in the Walker B motif of NBD2 (D1470N). Experiments were done with internal ATP (1 mM). In SUR2A/Kir6.2 channels, the K708A mutation abolished, and the K1349A but not D1470N mutation reduced the sensitivity to nicorandil. ADP (100 microM) significantly increased the wild-type channels' sensitivity to nicorandil, which was abolished by the K1349A or D1470N mutation. Thus, the SUR2A/Kir6.2 channels' response to nicorandil critically depends on ATP-NBD1 interaction and is facilitated by interactions of ATP or ADP with NBD2. In SUR2B/Kir6.2 channels, either the K708A or K1349A mutation partially suppressed the response to nicorandil, and double mutations abolished it. The D1470N mutation also significantly impaired the response. ADP did not sensitize the channels. Thus, NBD2 hydrolyzes ATP, and NBD1 and NBD2 equally contribute to the response by interacting with ATP and ADP, accounting for the higher nicorandil sensitivity of SUR2B/Kir6.2 than SUR2A/Kir6.2 channels in the presence of ATP alone. Thus, C42 modulates the interaction of both NBDs with intracellular nucleotides.
机译:尼古丁可激活由Kir6.2和磺酰脲受体(SUR)2A或2B组成的ATP敏感K(+)通道。尽管SUR2A和SUR2B仅在其C端42个氨基酸(C42)上不同,并且具有相同的药物受体和核苷酸结合域(NBD),但尼古地尔比SUR2A / Kir6.2通道更有效地激活SUR2B / Kir6.2。在这里,我们用膜片钳方法的内外构型分析了NBD在这些通道对尼古丁的反应中的作用。 NBD1的Walker A基序(K708A)和NBD2(K1349A)和NBD2的Walker B基序(D1470N)中的突变削弱了NBD核苷酸的结合和水解。使用内部ATP(1 mM)进行实验。在SUR2A / Kir6.2通道中,K708A突变被废除,而K1349A而非D1470N突变则降低了对尼可地尔的敏感性。 ADP(100 microM)显着提高了野生型通道对尼可地尔的敏感性,这已被K1349A或D1470N突变所废除。因此,SUR2A / Kir6.2通道对尼古丁的反应关键取决于ATP-NBD1的相互作用,并且通过ATP或ADP与NBD2的相互作用而得到促进。在SUR2B / Kir6.2通道中,K708A或K1349A突变都部分抑制了对尼可地尔的反应,而双重突变则消除了它。 D1470N突变也大大削弱了反应。 ADP没有使渠道敏感。因此,NBD2水解ATP,并且NBD1和NBD2通过与ATP和ADP相互作用同样有助于反应,这说明在单独存在ATP的情况下,SUR2B / Kir6.2通道的尼古丁敏感性高于SUR2A / Kir6.2通道。因此,C42调节两个NBD与细胞内核苷酸的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号